SureTrader SureTrader
Home > Boards > US OTC > Miscellaneous >

ViaDerma Inc. (VDRM)

VDRM RSS Feed
Add VDRM Price Alert      Hide Sticky   Hide Intro
Moderator: mick, BERKSHIRE AGENT , CMIH, $Pistol Pete$
Search This Board:
Last Post: 9/27/2016 4:17:37 PM - Followers: 93 - Board type: Free - Posts Today: 3

VDRM

ViaDerma, Inc.

A Division of ViaDerma, Inc. , A Public Company.

Breakthrough Rapid Delivery of Nutrients and Medicines

ViaDerma, Inc. is a biotechnology licensing company committed to bringing new products quickly to the pharmaceutical industry through innovative research & development. ViaDerma licenses products in fields of medicine ranging from infectious diseases to stem-cell therapy.

About Our Products

 

Proprietary and Trade Secret Mechanism of Action

ViaDerma's proprietary transdermal delivery system allows for rapid mass transfer of the pharmaceutical active ingredient across the skin and into the body to provide immediate localized therapy.

The technology allows transfer of chemicals through the stratum corneum (outer layer of skin) with a diffusion constant which is 10,000 times higher than the diffusion constant which characterizes water movement through the stratum corneum.

This enables ViaDerma to pair almost any active ingredient with the technology and provide rapid transport of the medicine right to the site of action.

The first product is a broad spectrum tetracycline-based topical antibiotic is the only antibiotic in the world that kills bacteria both a physical and a chemical mechanism. All known antibiotics (other than ours) primarily use only a chemical mechanism of kill. The physical mechanism of kill is a key feature of what we call Rapid Active Ingredient Delivery System (RAIDS). One result of RAIDS is that tetracycline is carried in higher concentrations, more quickly, to and through the cell walls, where the tetracycline can become more effective than if conventional antibiotics were used. Conventional antibiotics require more time (usually prescribed for 5 to 7 days for best results), whereas our tetracycline-based products usually produce desirable results in 24 hours (or less) because of the RAIDS effect.

Skin Layer Organization

A second important result of RAIDS is that the topical antibiotic kills all harmful Gram positive and Gram negative bacteria that have been available for testing. We believe this is the world’s strongest broad-spectrum topical antibiotic available.

The potential commercial impact is immense. Drug developers believe it takes much longer for bacteria to develop drug resistance to a physical kill mechanism. This is because it is relatively easy for bacteria to change their response to a chemical threat, but it takes numerous generations for bacteria to grow a new kind of cell wall structure to respond to a physical threat.

Our novel approach to overcome drug resistance of antibiotics is designed to sustain the effectiveness of antibiotics and other topical drugs for many years. This gives new topical drug products a longer useful lifetime and therefore more commercial value. This technology, when licensed to larger pharmaceutical companies, may provide stronger incentive for the discovery and development of new antimicrobial drugs. In recent years, the dearth of new antibiotics has been largely due to the uncertain new-drug commercial lifetime which is diminished when bacteria develop immunity to that drug.

In addition the technology can be licensed to other companies to convert existing oral drugs to transdermal medications extending the profitably of the existing drug.

APPLICATIONS & USAGE

We are developing products in the following fields of use;

Topical antibiotics

Treats all types of bacteria including MRSA, VRE and other flesh eating bacteria. Fights drug resistant bacteria. $6B/year global market.

  • Estimated Global prevalence rate of all types of bacterial infection including pets: 2 Billion.
    Estimated Global prevalence rate of MRSA: 140 million.
Topical toenail antifungal

Onychomycosis, a fungal infection of the toenails, is a major health problem. It is estimated that there are in excess of 40 million sufferers with this condition in the USA. It is a problem throughout the world. A recent European study showed that the prevalence of Onychomycosis may be as high as 26.9%. Fungal resistance can occur when the oral antifungal agents are used on a long-term basis. Topically applied antifungal drugs may work somewhat better adjunctive to surgical removal or chemical dissolution of the nail plate. Yet, this often ineffective and traumatic procedure leaves the subject without a nail for months at risk for re-infection. Given the limitations of current treatment options in this $3B market, there is a great need for a simple, nontoxic and effective alternative treatment. Estimated Global prevalence rate: 140 million.

Anti-viral formula

Treats symptoms of Influenza which is a$4B/ year global market: Common

  • Estimated Global prevalence rate of Influenza: 355-1065 million.
    Estimated Global prevalence rate of “Bird Flu”: Very rare, about 500 cases.
    Estimated Global prevalence rate of “Swine Flu”: 1420 million were infected in 2009
Wound care

Diabetic foot wounds.

  • Diabetic foot Ulcers; $1.5B/year global market. 12 million people per year

Contact Details

ViaDerma's global headquarters is located at
8950 W. Olympic Blvd, Suite 576, Beverly Hills, CA 90211.

We are currently in discussions with companies in Australia & New Zealand, India, China, and West Africa.

Phone: 310.871.3996

Headlines Get Headlines for:

Tuesday, August 5, 2014

Tuesday, June 10, 2014

Older Headlines - Most Recent Headlines

-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
HUGE:
 

TetraStem, Lead Product of ViaDerma, Inc., Hopes to Slow Rates of Diabetic Amputations

GlobeNewswire via CMTX - Fri Nov 07, 7:54AM CST

ViaDerma, Inc. (OTCQB:VDRM), a specialty pharmaceutical company devoted to bringing new products to market, has recently released a revolutionary new wound care drug called TetraStem. TetraStem is a topical liquid tetracycline-based antibiotic that uses a patent-pending innovative transdermal delivery system that has shown success in aiding the healing of diabetic wounds and therefore preventing amputations.

Diabetes is a serious medical condition that affects how the body uses blood sugar. Because glucose is vital for your cells to have enough energy, too much of it can lead to major medical problems such as amputations. In 2010, roughly 8% of the American population had diabetes, or 25.8 million people. Of those 25.8 million diagnosed diabetics, 73,000 adults had non-traumatic lower-limb amputations, according to the American Diabetes Association.

TetraStem has shown success in laboratory trials and found to be 99 percent effective against all bacteria. ViaDerma believes the application of TetraStem can maximize the healing of diabetic wounds before they require amputation.

"TetraStem kills infection because of the proprietary, transdermal delivery that allows TetraStem to kill bacteria chemically and physically," says CEO of ViaDerma, Dr. Christopher Otiko. "We hope that the application of TetraStem can help reduce the number of amputations from diabetic wounds, thereby saving lives and increasing people's quality of life."


-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
 

Authorized Shares: 150,000,000 a/o April 4, 2016

Outstanding Shares: 125,042,787 a/o April 4, 2016

Float: 51,061,509 a/o March 31, 2016

Par Value    0.001

-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

$VDRM COULD BE THE pharmacy stock of the year. This stock could run 30,000% here's why.

1) EXTREMELY OVERSOLD and unknown 
2) ONLY 150 MILLION A\S! Makes it the TINIEST FLOAT VS PRICE out of ALL pharmacy stockso in the whole country!
3) Pharmaceutical stocks have the LARGEST PERCENTAGE GAINS OUT OF ALL STOCKS IN THE MARKET on the big boards or the OTHER. 
4) Unusual sudden MASSIVE increase in volume since 3/7/16 LOOK.
5) INSIDERS OWN 75 MILLION SHARES, that's right 75 MILLION!
6) WON AWARD FOR THEIR DRUG
7) STRONG HANDS HOLDING 11 million shares out of the TINY 18 million float.
8) After being silent for ages 4 JUICY FILINGS came out in September so something could be up.
9) THEY HAVE A PATENT which big boys have to be eyeing.

VDRM IS A HIDDEN GOLDMINE

THIS IS NOT A REGULAR PENNY STOCK. The LOWEST FLOAT vs price vs ALL PHARMA STOCKS IN THE COUNTRY. BIG BOARD OR OTC LAND. ALL OF THEM. Pharma stocks have the HIGHIGHEST EST percentage gain in big boards or penny stocks
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
VDRM
Current Price
Volume:
Bid Ask Day's Range
SureTrader
PostSubject
#3267  Sticky Note VDRM awesome website! Check out the products they carry BERKSHIRE AGENT 07/22/16 01:13:46 AM
#1446  Sticky Note $VDRM Honors and Awards $Pistol Pete$ 06/30/15 08:40:10 PM
#3392   Top 5 fraud OTC, stay away folks beargroup 09/27/16 04:17:37 PM
#3391   There hasn't been any liquidity lately. For someone Herciphicles 09/27/16 08:06:31 AM
#3390   Interesting volume today. I've been around in this CMIH 09/27/16 12:57:56 AM
#3389   All that volume today was you? I'm gonna Herciphicles 09/26/16 10:07:33 PM
#3388   Got some today Smarttrader25 09/26/16 07:34:58 PM
#3387   Actually never mind about the first comment... this CMIH 09/25/16 02:13:38 PM
#3386   From the name you reference it sounds like CMIH 09/25/16 02:11:39 PM
#3385   Looks like they've changed the name of their Herciphicles 09/21/16 06:25:02 PM
#3384   Viaderma, Inc. (PC) (VDRM) mick 09/18/16 11:55:49 AM
#3383   I'm here. Checking in occasionally. Seems This thing Herciphicles 09/18/16 10:41:25 AM
#3382   Anyone home? CMIH 09/15/16 03:52:38 PM
#3381   Take a look at that bid CMIH 09/06/16 11:29:51 AM
#3380   Pathetic isn't it? Don 09/03/16 11:08:14 PM
#3379   Viaderma, Inc. (PC) (VDRM) mick 09/03/16 04:01:01 PM
#3378   $VDRM http://www.barchart.com/interactive_charts/stocks/ $Pistol Pete$ 09/02/16 09:29:34 PM
#3376   100k share trade and we're up 41% can CMIH 08/29/16 12:26:38 PM
#3375   $VDRM Daily Chart http://stockcharts.com/c-sc $Pistol Pete$ 08/28/16 10:37:40 PM
#3374   As the result of a legal action for brunners 08/26/16 08:33:49 AM
#3373   On July 22, 2016, the Company issued 10,526,316 brunners 08/26/16 08:32:58 AM
#3372   In August of 2016, the Company issued total brunners 08/26/16 08:32:40 AM
#3371   This is sooo Cheap HELLO! techtrader01 08/24/16 11:45:12 PM
#3370   Even if VDRM bought out DCRD, their previous thestockartist 08/18/16 06:31:37 PM
#3369   Where is the patent information? It states here thestockartist 08/18/16 06:11:18 PM
#3368   sounds good, james bond. however, it can hit excelsiorvision 08/18/16 05:12:32 PM
#3363   I only posted link to arrest to answer thestockartist 08/18/16 12:14:04 PM
#3362   You are an aggressive iHubber IMVHO MasterBidder 08/18/16 12:07:19 PM
#3360   Reads to me like he was the fall MasterBidder 08/18/16 10:45:59 AM
#3359   This is almost 10 years old anything more offensiveortiz 08/18/16 10:10:07 AM
#3358   Here is the link for arrest: https://www.dea.gov/pubs/states/newsrel/atlanta0723 thestockartist 08/17/16 10:52:41 PM
#3357   The spread is too wide now....needs volume and IPO$ 08/17/16 10:31:35 PM
#3356   .23 is nice but let's start with .007 IPO$ 08/17/16 10:30:45 PM
#3355   What is the link for an arrest please? IPO$ 08/17/16 10:29:35 PM
#3353   I showed proof of Chris Otiko being arrested, thestockartist 08/17/16 06:20:37 PM
#3352   A lot of fools coming to this board excelsiorvision 08/17/16 02:35:37 PM
#3351   Only thing it's about right now is patience. Batman412 08/17/16 12:35:43 PM
#3347   LMFAOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOO. Some people REALLY need to give up Angel010910 08/16/16 12:43:53 PM
#3346   He actually was acquitted of all 28 counts Batman412 08/16/16 12:15:56 PM
#3345   Don't believe this guy telling you that VDRM thestockartist 08/16/16 12:00:12 AM
#3344   Viaderma, Inc. (PC) (VDRM) mick 08/13/16 05:21:18 PM
#3343   all talk IN The Mouth Of Madness 08/05/16 04:09:46 PM
#3342   Here: MasterBidder 08/05/16 12:52:06 PM
#3341   All this talk about a run, buy out, Dumotier21 08/05/16 10:38:21 AM
#3340   Shes primed for a run $$$ slickinvest 08/05/16 08:47:37 AM
#3339   This can run past $0.50 without the buyout. excelsiorvision 08/04/16 04:46:47 PM
#3338   Yep, someone loaded da boat a few weeks Don 08/04/16 02:47:58 PM
#3337   Wouldn't want to be without shares of this CMIH 08/04/16 02:04:43 PM
#3336   LETS SEE THAT HUGE BUYOUT AT .50+....VDRM IS halbroke1 08/04/16 12:22:19 PM
#3335   LMFAOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOO people love to talk out their but Angel010910 08/02/16 10:22:41 PM
#3334   I'm hoping for .007 ST. IPO$ 08/02/16 07:47:55 PM
#3333   And only down 32% interday... Perhaps after the Don 08/02/16 02:50:03 PM
PostSubject